To promote the Cancer Research Institute’s global awareness campaign, Cancer Immunotherapy Month, ACEA Biosciences will be participating in the #WearWhite campaign on June 15 and providing an Immunotherapy Research Grant to help scientists in the field of cancer research achieve their goals. As a leading innovator in the development of tools for the cancer research […]
Under this agreement, MaxCyte’s second signed with a U.S. NIH institute in the past year, the Company and the National Heart, Lung, and Blood Institute will explore development of new therapies for sickle cell disease using MaxCyte’s gene-correction platform Gaithersburg, Maryland – MaxCyte, Inc. today announces it has entered into a Cooperative Research and Development Agreement (“CRADA”) […]
New publication maps ligase fidelity profiles with single molecule real-time sequencing to enable 20+ fragment assemblies with high efficiency and accuracy IPSWICH, MA, USA — Some of today’s most exciting molecular biology engineering — including the creation of customized CRISPR/Cas9 and TALEN constructs for genome editing — are led by synthetic biologists. These scientists are […]
Utrecht, The Netherlands Continuing its customer-centric approach, and fulfilling its commitment to providing preclinical imaging systems of unmatched price/performance, MILabs has introduced its E-Class of tomographic imaging products. The E-Class imagers were specifically designed for ambitious researchers to start their research now, and who want the option to easily upgrade the same system in the […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of QT Holdings Corporation d/b/a Quad Technologies. The transaction is expected to close in early July and to be financed through available cash on hand. “We are extremely excited to welcome Quad Technologies and its line of advanced […]
Engineered Cells single-click ordering and knockout guarantee removes barriers to world-class CRISPR results REDWOOD CITY, California — Synthego, the leading genome engineering solutions company, launches its Engineered Cells Portfolio with immediate access to Knockout Clone & Pool, and Advanced Cells. The Knockout Clone and Pool products enable single-click online ordering of any human cell line with […]
Opens North America’s first BioReliance® End-to-End Biodevelopment Center to help customers with biopharmaceutical manufacturing processes Accelerates clinical development from DNA to market “Advance Biotech Grant Program” expands global biotech commitment to help awardees accelerate process set-up with MilliporeSigma services, expertise Burlington, Massachusetts — MilliporeSigma today officially opened North America’s first BioReliance® End-to-End Biodevelopment Center providing cell line development […]
AYOXXA launches LUNARIS(TM) Human & Mouse 6-Plex T Cell Characterization Kits to elucidate T cell differentiation LUNARISTM: Human & Mouse 6-Plex T Cell Characterization Kits are validated for quantitative analysis of soluble effector molecules secreted by distinct T cell populations, including IFN-γ, IL-2, IL-4, IL-17A, TGF-β1, and Granzyme B The accurate and reproducible generation of […]
MONROE, N.C.–Greiner Bio-One North America, Inc. is announcing the creation of a patient-derived xenograft model for inflammatory breast cancer (IBC) using magnetic 3D cell culture research methods that mimic the current patient-derived xenograft (PDX) model standard. This new and effective methodology will provide a more efficient method to combat one of the most aggressive forms […]
TOKYO — FUJIFILM Corporation (President: Kenji Sukeno) announced today that it has completed the acquisition of Irvine Scientific Sales Company, Inc. (ISUS) and IS JAPANCO.,LTD. (ISJ), leading companies in cell culture media for about US$800 million on June 1 in the United States. To advance its growth strategies in the healthcare area, Fujifilm continues to invest in contract development and manufacturing of biopharmaceuticals and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
